Amazon Web Services (AWS) is teaming up with EvolutionaryScale, a biology-focused artificial intelligence company, to offer scientists and researchers access to the startup’s ESM3 language models via AWS. This collaboration aims to advance drug discovery by facilitating the development of new proteins. EvolutionaryScale recently secured $142 million in seed funding, with support from Nat Friedman, … Read more
EvolutionaryScale, a US AI startup, recently secured $142 million in seed funding to develop AI technology capable of generating new proteins for various scientific and medical applications. The funding will enhance the company’s collaboration with the biotech industry. EvolutionaryScale, founded in 2023, is supported by major companies like Amazon Web Services (AWS) and NVIDIA. The … Read more
EvolutionaryScale, a US AI startup, has secured $142 million in seed funding to develop AI technology that can generate new proteins for research, drug discovery, and medical therapies. The funding will strengthen the company’s partnership with the biotech industry. EvolutionaryScale, founded in 2023, is supported by major companies like Amazon Web Services (AWS) and NVIDIA. … Read more